Synutra Announces Preliminary Fourth Quarter and Full Year 2014 Financial Results

  Synutra Announces Preliminary Fourth Quarter and Full Year 2014 Financial

-- Provides Preliminary FY15 Growth Forecast --

PR Newswire

QINGDAO, China and ROCKVILLE, Md., May 12, 2014

QINGDAO, China and ROCKVILLE, Md., May 12, 2014 /PRNewswire/ -- Synutra
International, Inc. (NASDAQ: SYUT), ("Synutra" or the "Company"), which owns
subsidiaries in China that produce, distribute and sell nutritional products
for infants, children and adults, today announced unaudited preliminary fourth
quarter and full year 2014 results.

For the fourth quarter ended March 31, 2014, the Company anticipates revenue
of approximately $99.5 million, including $89.1 million from the formula
segment, and net income in the range of $10-11 million. This equates to full
year 2014 revenue and net income of approximately $371 million and $30-$32
million, respectively.

Mr. Liang Zhang, Chairman and CEO of Synutra said, "Our business momentum
continued to improve in our fiscal fourth quarter with sequential increases in
both formula segment revenue and net profit. Our success in the fourth quarter
was due to increased shipment volumes driven by the spring holiday season as
well as our increased marketing efforts. Our fourth quarter profit improved
over the previous quarter as we drove greater efficiency in our sales &
promotion structure. We expect continued strong top line growth and greater
operating leverage in fiscal 2015, with full year revenue growth expected to
be at least 20% over fiscal 2014 results, or between $450 to $500 million, and
net profit growth expected to be at least 60%, or between $50 to 60 million."

Synutra plans to report its fourth quarter and full year 2014 results and
provide greater visibility to its FY15 growth expectations in mid-June. The
estimates presented in this press release are preliminary, unaudited and
subject to further adjustments.

About Synutra International, Inc.

Synutra International, Inc. (Nasdaq: SYUT) is a leading infant formula company
in China. It principally produces, markets and sells its products through its
operating subsidiaries under the "Shengyuan" or "Synutra" name, together with
other complementary brands. It focuses on selling premium infant formula
products, which are supplemented by more affordable infant formulas targeting
the mass market as well as other nutritional products and ingredients. It
sells its products through an extensive nationwide sales and distribution
network covering all provinces and provincial-level municipalities in mainland
China. As of December 31, 2013, this network comprised over 670 independent
distributors and over 620 independent sub-distributors who sell Synutra
products in approximately 28,000 retail outlets.

Forward-looking Statements

This press release contains "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995 that are based on our
current expectations, assumptions, estimates and projections about Synutra
International, Inc. and its industry. All statements other than statements of
historical fact in this release are forward-looking statements. In some cases,
these forward-looking statements can be identified by words or phrases such as
"anticipate," "believe," "continue," "estimate," "expect," "intend," "is/are
likely to," "may," "plan," "should," "will," "aim," "potential," "continue,"
or other similar expressions. The forward-looking statements included in this
press release relate to, among others, Synutra's goals and strategies; its
future business development, financial condition and results of operations,
particularly the progress on the new drying facility project in France; the
expected growth of the nutritional products and infant formula markets in
China; market acceptance of Synutra's products; the safety and quality of
Synutra's products; Synutra's expectations regarding demand for its products;
Synutra's ability to stay abreast of market trends and technological advances;
competition in the infant formula industry in China; PRC governmental policies
and regulations relating to the nutritional products and infant formula
industries, and general economic and business conditions in China. These
forward-looking statements involve various risks and uncertainties. Although
Synutra believes that the expectations expressed in these forward-looking
statements are reasonable, these expectations may turn out to be incorrect.
Synutra's actual results could be materially different from the expectations.
Important risks and factors that could cause actual results to be materially
different from expectations are generally set forth in Synutra's filings with
the Securities and Exchange Commission. The forward-looking statements are
made as of the date of this press release. Synutra International, Inc.
undertakes no obligation to update any forward-looking statements to reflect
events or circumstances after the date on which the statements are made or to
reflect the occurrence of unanticipated events.

SOURCE Synutra International, Inc.

Contact: Synutra International, Inc., Investor Relations Department, or 646-328-2552
Press spacebar to pause and continue. Press esc to stop.